Drug profile · INN
dacomitinib
VIZIMPRO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
dacomitinib (VIZIMPRO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN dacomitinib
Brand VIZIMPRO
Route ORAL
Formulation TABLET
ATC code L01EB07
Frequently asked questions
What is dacomitinib?
dacomitinib (VIZIMPRO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for dacomitinib?
VIZIMPRO is a marketed brand name for dacomitinib. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dacomitinib?
dacomitinib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.